Huahui Health CSO Li Wenhui sits down with Scrip in the office to discuss many of the key issues such as, how he views antivirals development post-COVID? how the company’s hepatitis drugs differentiated from others? Given the current antivirals from Gilead among others, why Li believed that the antiviral development remains vital?

Biotech CEO podcast with Huahui CSO Li Wenhui

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.